Reich Siegfried 4
4 · Turning Point Therapeutics, Inc. · Filed Mar 2, 2020
Insider Transaction Report
Form 4
Reich Siegfried
EVP & Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2020-03-02+150,000→ 150,000 totalExercise: $51.28Exp: 2030-03-01→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest on March 2, 2021 and 1/48th of the shares vest monthly thereafter over the next three years.